Interleukin-1β is a Potential Therapeutic Target for Periodontitis: a Narrative Review

Ran Cheng,Zhiwu Wu,Mingming Li,Meiying Shao,Tao Hu
DOI: https://doi.org/10.1038/s41368-019-0068-8
IF: 24.897
2020-01-01
International Journal of Oral Science
Abstract:Interleukin(IL)-1 beta, a pro-inflammatory cytokine, was elevated and participates in periodontitis. Not only the link between IL-1 beta and periodontitis was proved by clinical evidence, but also the increased IL-1 beta triggers a series of inflammatory reactions and promotes bone resorption. Currently, IL-1 beta blockage has been therapeutic strategies for autoimmune and autoinflammatory diseases such as rheumatoid arthritis, cryopyrin-associated periodic syndromes, gout and type II diabetes mellitus. It is speculated that IL-1 beta be a potential therapeutic target for periodontitis. The review focuses on the production, mechanism, present treatments and future potential strategies for IL-1 beta in periodontitis.
What problem does this paper attempt to address?